IBA Dosimetry to showcase DOLPHIN advancements enabling verification of the complete radiotherapy treatment chain

IBA, the world’s leading provider of proton therapy solutions and radiation therapy integrated quality assurance for the treatment of cancer, today announced it will be demonstrating the latest version of its DOLPHIN solution for advanced patient quality assurance, at ESTRO 37, booth 1500.
DotMed